MCM
ALT icon

MAI Capital Management’s Altimmune ALT Stock Holding History

MAI Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462 Hold
150
– – ﹤0.01% 4435
2025
Q4 		$542 Hold
150
– – ﹤0.01% 3808
2025
Q3 		$566 Buy
+150
New +$579 ﹤0.01% 3599

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MAI Capital Management's ALT Position: Q1 2026 in Review

MAI Capital Management held its Altimmune (ALT) position steady in Q1 2026 at 150 shares worth $462. The position accounts for ﹤0.01% of the portfolio, ranked #4435.

MAI Capital Management first reported a position in ALT in Q3 2025 and has held it in 3 quarters since. The position peaked at $566 in Q3 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • MAI Capital Management held 150 shares of Altimmune worth $462 as of Q1 2026.
  • MAI Capital Management left its Altimmune share count unchanged in Q1 2026.
  • Altimmune made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4435 holding.
  • MAI Capital Management first reported a position in Altimmune in Q3 2025 and has held it in 3 quarters since.
  • MAI Capital Management's Altimmune position peaked at $566 in Q3 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.